Sign inJoin waitlistJoin the waitlist

Sydney Montesi

Associate Professor of Medicine · Harvard Medical School

Credentials: · · · · ·

History

Harvard Medical School
Present

Pulmonary Disease
2014–2016
Massachusetts General Hospital
2013–2014
Internal Medicine
University of Virginia Medical Center
2008–2011
Internal Medicine
Massachusetts General Hospital
2008–2011
University of Rochester School of Medicine and Dentistry
2004–2008

Research

The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials
Systematic review or meta-analysis · Journal of Clinical Sleep Medicine · 2012 · First of 4 authors · 242 citations
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine · 2024 · 150 citations
Prone positioning reduces mortality from acute respiratory distress syndrome in the low tidal volume era: a meta-analysis
Systematic review or meta-analysis · Intensive Care Medicine · 2014 · 140 citations

Barry Shea
14 papers
Lida Hariri
11 papers
Ganesh Raghu
9 papers
AS
Amita Sharma
8 papers
CR
Christopher Ryerson
8 papers
Atul Malhotra
7 papers
Ayodeji Adegunsoye
7 papers
Fernando Martinez
7 papers
Richard Silver
7 papers
Tanzib Hossain
7 papers
Derrick Herman
6 papers
FF
Florian Fintelmann
6 papers

Grants

Advanced Imaging for Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.8M · Massachusetts General Hospital
2024–2029
Vascular Leak and Outcomes in IPF
National Heart, Lung, and Blood Institute · K23
Contact PI · $886.7K · Massachusetts General Hospital
2020–2026
Assessing Disease Activity in IPF with Novel Biomarkers and Molecular Imaging
National Heart, Lung, and Blood Institute · F32
Contact PI · $130.6K · Massachusetts General Hospital
2015–2017

Clinical trials

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
Principal investigator · Not yet recruiting · Phase 3
University of Massachusetts, Worcester
2026–2029
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Principal investigator · Recruiting · Phase 2
Peter Caravan
2026–2028
Advanced Imaging for Pulmonary Fibrosis
Principal investigator · Recruiting · Phase 2
Peter Caravan
2025–2028
Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients
Principal investigator · Completed · Phase 1
Hal Chapman
2023–2026